{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:12:45Z","timestamp":1774314765122,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11987-z","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:24:44Z","timestamp":1762874684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bacteraemia due to E.coli in urinary tract infections in adults: a prospective epidemiological study following implementation of guidelines in a regional hospital"],"prefix":"10.1186","volume":"25","author":[{"given":"David","family":"Blancas-Altabella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella F.","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Chico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Serd\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eul\u00e0lia","family":"Jou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Moreno-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Carmezim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Garc\u00eda-Pont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"11","key":"11987_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.amjmed.2006.03.034","volume":"119","author":"A Fraser","year":"2006","unstructured":"Fraser A, Paul M, Almanasreh N, Tacconelli E, Frank U, Cauda R, et al. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med. 2006;119(11):970\u20136.","journal-title":"Am J Med"},{"issue":"2","key":"11987_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","volume":"49","author":"CI Kang","year":"2005","unstructured":"Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"11987_CR3","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1378\/chest.09-0087","volume":"136","author":"A Kumar","year":"2009","unstructured":"Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237\u201348.","journal-title":"Chest"},{"issue":"10","key":"11987_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s10096-017-3009-5","volume":"36","author":"M Tsuboi","year":"2017","unstructured":"Tsuboi M, Hayakawa K, Mezaki K, Katanami Y, Yamamoto K, Kutsuna S, et al. Impact of prompt intervention in response to positive blood culture results during weekends by collaboration between infectious disease specialists and microbiology laboratory staff. Eur J Clin Microbiol Infect Dis. 2017;36(10):1889\u201397.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"11987_CR5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/cid\/ciaa210","volume":"72","author":"M Bonten","year":"2021","unstructured":"Bonten M, van den Johnson JR, Georgalis L, Geurtsen J, de Palacios PI, Gravenstein S, Verstraeten T, Hermans P, Poolman JT. Epidemiology of Escherichia coli bacteremia: a systematic literature review. Clin Infect Dis. 2021;72(7):1211\u20139.","journal-title":"Clin Infect Dis"},{"key":"11987_CR6","unstructured":"Smith DA, Nehring SM. Bacteremia. StatPearls. Treasure Island (FL)2024."},{"issue":"7","key":"11987_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/cid\/ciaa210","volume":"72","author":"M Bonten","year":"2021","unstructured":"Bonten M, van den Johnson JR, Georgalis L, Geurtsen J, de Palacios PI, et al. Epidemiology of Escherichia coli bacteremia: A systematic literature review. Clin Infect Dis. 2021;72(7):1211\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11987_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13017-023-00518-3","volume":"18","author":"Worldwide Antimicrobial Resistance National\/International Network Group C","year":"2023","unstructured":"Worldwide Antimicrobial Resistance National\/International Network Group C. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. World J Emerg Surg. 2023;18(1):50.","journal-title":"World J Emerg Surg"},{"key":"11987_CR9","unstructured":"World Health Organization factsheet: Antimicrobial resistance [updated November 21. 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"issue":"1","key":"11987_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12879-021-06326-x","volume":"21","author":"MC MacKinnon","year":"2021","unstructured":"MacKinnon MC, McEwen SA, Pearl DL, Lyytikainen O, Jacobsson G, Collignon P, et al. Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study. BMC Infect Dis. 2021;21(1):606.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"11987_CR11","doi-asserted-by":"publisher","first-page":"106943","DOI":"10.1016\/j.ijantimicag.2023.106943","volume":"62","author":"M Batlle","year":"2023","unstructured":"Batlle M, Badia JM, Hernandez S, Grau S, Padulles A, Boix-Palop L, et al. Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study. Int J Antimicrob Agents. 2023;62(5):106943.","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 3","key":"11987_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0213-005X(12)70089-7","volume":"30","author":"F Gudiol","year":"2012","unstructured":"Gudiol F, Limon E, Fondevilla E, Argimon JM, Almirante B, Pujol M. The development and successful implementation of the VINCat program. Enferm Infecc Microbiol Clin. 2012;30(Suppl 3):3\u20136.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"11987_CR13","unstructured":"Programa de vivil\u00e0ncia de les infeccions relacionades amb l\u2019atenci\u00f3 sanitaria de. Catalunya (VINCat) Manual VINCat [updated 2023. Available from: https:\/\/scientiasalut.gencat.cat\/bitstream\/handle\/11351\/7722.2\/programa_vigilancia_infeccions_relacionades_atencio_sanitaria_catalunya_manual_vincat_2023.pdf?sequence=8%26isAllowed=y"},{"key":"11987_CR14","unstructured":"CatSalut. Servei Catal\u00e0 de la Salut. VINCat [Available from: https:\/\/catsalut.gencat.cat\/ca\/proveidors-professionals\/vincat\/"},{"issue":"10","key":"11987_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791\u20137.","journal-title":"Ann Intern Med"},{"key":"11987_CR16","unstructured":"Guanabara E, Ltda K, Guanabara E, Ltda K. The European Committee on An-timicrobial Susceptibility Testing. Clinical Breakpoints-Bacteria (v 7.1\u201311.0). n.d. https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"11987_CR17","doi-asserted-by":"crossref","unstructured":"Campos AF, Arantes T, Cambiais A, Cury AP, Tiroli CG, Rossi F et al. Impact of an antimicrobial stewardship program intervention associated with the rapid identification of microorganisms by MALDI-TOF and detection of resistance genes in ICU patients with Gram-Negative bacteremia. Antibiot (Basel). 2022;11(9).","DOI":"10.3390\/antibiotics11091226"},{"issue":"12","key":"11987_CR18","doi-asserted-by":"publisher","first-page":"ofz490","DOI":"10.1093\/ofid\/ofz490","volume":"6","author":"RM Erickson","year":"2019","unstructured":"Erickson RM, Tritle BJ, Spivak ES, Timbrook TT. Impact of an antimicrobial stewardship bundle for uncomplicated Gram-Negative bacteremia. Open Forum Infect Dis. 2019;6(12):ofz490.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"11987_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/1120009X.2020.1755589","volume":"32","author":"R Moghnieh","year":"2020","unstructured":"Moghnieh R, Awad L, Abdallah D, Jadayel M, Sinno L, Tamim H, et al. Effect of a handshake stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome. J Chemother. 2020;32(7):368\u201384.","journal-title":"J Chemother"},{"issue":"5","key":"11987_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/cid\/ciab126","volume":"73","author":"ED Robinson","year":"2021","unstructured":"Robinson ED, Stilwell AM, Attai AE, Donohue LE, Shah MD, Hill BK, et al. Implementation of a rapid phenotypic susceptibility platform for Gram-Negative bloodstream infections with paired antimicrobial stewardship intervention: is the juice worth the squeeze? Clin Infect Dis. 2021;73(5):783\u201392.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"11987_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/jac\/dkad160","volume":"78","author":"M Ronda","year":"2023","unstructured":"Ronda M, Padulles A, Grau I, Tubau F, Satorra P, Shaw E, et al. Impact of a prospective audit and feedback antimicrobial stewardship programme on carbapenem consumption: a quasi-experimental study (IPANEMA study). J Antimicrob Chemother. 2023;78(7):1705\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"11987_CR22","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jiac.2019.05.026","volume":"25","author":"K Yamada","year":"2019","unstructured":"Yamada K, Imoto W, Yamairi K, Shibata W, Namikawa H, Yoshii N, et al. The intervention by an antimicrobial stewardship team can improve clinical and Microbiological outcomes of resistant gram-negative bacteria. J Infect Chemother. 2019;25(12):1001\u20136.","journal-title":"J Infect Chemother"},{"key":"11987_CR23","doi-asserted-by":"crossref","unstructured":"Jover-Saenz A, Ramirez-Hidalgo M, Belles Belles A, Ribes Murillo E, Batlle Bosch M, Cayado Cabanillas J et al. Impact of a primary care antimicrobial stewardship program on bacterial resistance control and ecological imprint in urinary tract infections. Antibiot (Basel). 2022;11(12).","DOI":"10.3390\/antibiotics11121776"},{"issue":"Suppl 4","key":"11987_CR24","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/jac\/dkz284","volume":"74","author":"PRS Lagace-Wiens","year":"2019","unstructured":"Lagace-Wiens PRS, Adam HJ, Poutanen S, Baxter MR, Denisuik AJ, Golden AR, et al. Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16. J Antimicrob Chemother. 2019;74(Suppl 4):iv22\u201331.","journal-title":"J Antimicrob Chemother"},{"key":"11987_CR25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.2147\/IDR.S256131","volume":"13","author":"Z Naziri","year":"2020","unstructured":"Naziri Z, Derakhshandeh A, Soltani Borchaloee A, Poormaleknia M, Azimzadeh N. Treatment failure in urinary tract infections: A warning witness for virulent Multi-Drug resistant ESBL- producing Escherichia coli. Infect Drug Resist. 2020;13:1839\u201350.","journal-title":"Infect Drug Resist"},{"key":"11987_CR26","doi-asserted-by":"publisher","first-page":"w20110","DOI":"10.4414\/smw.2019.20110","volume":"149","author":"V Zanichelli","year":"2019","unstructured":"Zanichelli V, Huttner A, Harbarth S, Kronenberg A, Huttner B. Swiss centre for antibiotic resistance A. Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and proteus mirabilis urinary isolates from switzerland: retrospective analysis of data from a National surveillance network over an 8-year period (2009\u20132016). Swiss Med Wkly. 2019;149:w20110.","journal-title":"Swiss Med Wkly"},{"issue":"7159","key":"11987_CR27","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/bmj.317.7159.652","volume":"317","author":"MJ Struelens","year":"1998","unstructured":"Struelens MJ. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ. 1998;317(7159):652\u20134.","journal-title":"BMJ"},{"issue":"2","key":"11987_CR28","first-page":"136","volume":"31","author":"R Canton","year":"2018","unstructured":"Canton R, Loza E, Aznar J, Barron-Aduriz R, Calvo J, Castillo FJ, et al. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum beta-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011\u20132015). Rev Esp Quimioter. 2018;31(2):136\u201345.","journal-title":"Rev Esp Quimioter"},{"issue":"2","key":"11987_CR29","first-page":"145","volume":"32","author":"R Canton","year":"2019","unstructured":"Canton R, Loza E, Aznar J, Castillo FJ, Cercenado E, Fraile-Ribot PA, et al. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017). Rev Esp Quimioter. 2019;32(2):145\u201355.","journal-title":"Rev Esp Quimioter"},{"issue":"11","key":"11987_CR30","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/cid\/ciz1183","volume":"71","author":"C Peragine","year":"2020","unstructured":"Peragine C, Walker SAN, Simor A, Walker SE, Kiss A, Leis JA. Impact of a comprehensive antimicrobial stewardship program on institutional burden of antimicrobial resistance: A 14-Year controlled interrupted Time-series study. Clin Infect Dis. 2020;71(11):2897\u2013904.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"11987_CR31","doi-asserted-by":"publisher","first-page":"107202","DOI":"10.1016\/j.ijantimicag.2024.107202","volume":"64","author":"M Gimenez-Perez","year":"2024","unstructured":"Gimenez-Perez M, Hernandez S, Padulles A, Boix-Palop L, Grau S, Badia JM, et al. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia. Int J Antimicrob Agents. 2024;64(2):107202.","journal-title":"Int J Antimicrob Agents"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11987-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11987-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11987-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:41:43Z","timestamp":1762922503000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11987-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11987"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11987-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Bellvitge Hospital (Ref. PR066\/18). Patient data were anonymized, and so the requirement for informed consent was waived by the Ethics Committee of Bellvitge Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1544"}}